Sanara MedTech Inc. — Director's Dealing 2017

Apr 6, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: WOUND MANAGEMENT TECHNOLOGIES, INC. (WNDM)
CIK: 0000714256
Period of Report: 2015-02-20

Reporting Person: Siedhoff John Christopher (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-02-20	Common Stock	C	750000	—	Acquired	7000000	Direct
2017-02-27	Common Stock	A	150000	—	Acquired	7150000	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2015-02-20	Series D Preferred Stock	$	C	750	Disposed		Common Stock (750000)	Direct

Footnotes

F1: The Series D Preferred Stock was convertible on a 1,000-for-1 basis, into shares of the issuer's common stock, upon the issuer's charter being amended to increase the number of authorized shares of common stock from 100,000,000 to 250,000,000. The issuer's charter was amended to reflect such increase in the number of authorized shares of common stock effective February 20, 2015.